On World Alzheimer’s Day Swiss organisations have called for better framework conditions for the prevention, research and treatment of Alzheimer’s and other forms of dementia. They also expressed alarm at the ever-growing number of cases.
About 146,500 people with dementia live in Switzerland, with most suffering from Alzheimer’s. This number will more than double in the next three decades, Alzheimer Switzerland, Swiss Memory Clinics and the Synapsis Foundation said in a statement. They predict some 315,000 people will live with dementia in Switzerland in 2050.
The current care and treatment system will not be able to cope with such an increase, they said. This is because the treatment and care of people with dementia is very expensive and places a heavy burden on their relatives. Today dementia generates annual costs of about CHF11.8 billion ($12.7 billion). Of this, relatives take on about CHF5.5 billion through unpaid care and nursing services.
Greater efforts
The three national dementia organisations are therefore calling for greater efforts in research, prevention and the treatment and care of dementia patients.
Increased investment in research is necessary to discover the still largely unknown causes of dementia and to develop suitable approaches for diagnosis, treatment and care, they said. To this end, long-term funding programmes must be launched and reliable figures on dementia diseases must be collected.
There is also a need for rapid prevention and early detection programmes, as many dementia cases can be prevented and severe development can be delayed thanks to early detection. The organisations said diagnosis must be followed by dementia-specific counselling and support services for those affected.
The costs associated with care should also be recognised by law and financed accordingly, they said.
More
More
Swiss research played key role in new Alzheimer’s drug
This content was published on
A newly approved treatment for Alzheimer’s was built on the foundations of Swiss scientific research, says the University of Zurich.
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Study shows benefits of physical and cognitive play in dementia patients
This content was published on
Elderly participants who trained regularly on a fitness device developed by a Swiss company showed improvements in cognitive skills.
Swiss medical community stands up for Alzheimer patients
This content was published on
Leading Swiss medical institutions are calling for Alzheimer diagnosis and treatment to be reimbursed by compulsory health care institutions.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.